MicrobiologyAntimicrobial Agents and ChemotherapyPeer-reviewed
Fluoroquinolone resistance-conferring gyrA variants alter the fitness cost and potentiate the resistance of the zoliflodacin resistance mutation gyrB D429N in Neisseria gonorrhoeae
Aditi Mukherjee, Susanne Blomqvist, David Helekal…·Yonatan H. Grad
This study shows that gyrA variants from ciprofloxacin resistance increase zoliflodacin resistance and fitness cost of the gyrB D429N mutation in N. gonorrhoeae.
1 citation